Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
09/08/2024 22:41
Aug 9 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS INC FILES FOR NON TIMELY 10-Q WITH
U.S.
SEC
* EAGLE PHARMACEUTICALS INC - CONTINUING TO EVALUATE ITS
INTERNAL
CONTROL OVER FINANCIAL REPORTING
* EAGLE PHARMACEUTICALS INC - EXPECTS TO REPORT ITS
REMEDIATION
PLAN AND FURTHER INFORMATION REGARDING THE MATERIAL WEAKNESSES
IN THE REPORTS
Source text for Eikon: ID:n0001104659-24-087841
Further company coverage: EGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq